ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
Done
Inviting an author to review:
Of Other Spaces
Find an author and click ‘
Invite to review selected article
’ near their name.
Search for authors
Search for similar articles
Invite by email
32
views
0
references
Top references
cited by
368
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
3,422
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Trial of Psilocybin versus Escitalopram for Depression
Author(s):
Robin Carhart-Harris
1
,
Bruna Giribaldi
1
,
Rosalind Watts
1
,
Michelle Baker-Jones
1
,
Ashleigh Murphy-Beiner
1
,
Roberta Murphy
1
,
Jonny Martell
1
,
Allan Blemings
1
,
David Erritzoe
1
,
David J. Nutt
1
Publication date
Created:
April 15 2021
Publication date
(Print):
April 15 2021
Journal:
New England Journal of Medicine
Publisher:
Massachusetts Medical Society
Read this article at
ScienceOpen
Publisher
PubMed
Further versions
open (via free article)
Powered by
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Measurement of Glucocorticoid Receptor Signaling in Major Depression
Author and article information
Journal
Title:
New England Journal of Medicine
Abbreviated Title:
N Engl J Med
Publisher:
Massachusetts Medical Society
ISSN (Print):
0028-4793
ISSN (Electronic):
1533-4406
Publication date Created:
April 15 2021
Publication date (Print):
April 15 2021
Volume
: 384
Issue
: 15
Pages
: 1402-1411
Affiliations
[
1
]
From the Centre for Psychedelic Research, Department of Brain Sciences, Faculty of Medicine, Imperial College London, London.
Article
DOI:
10.1056/NEJMoa2032994
PubMed ID:
33852780
SO-VID:
e3f5875c-c98b-44ae-9427-22d9bcf5846b
Copyright ©
© 2021
License:
http://www.nejmgroup.org/legal/terms-of-use.htm
History
Data availability:
Comments
Comment on this article
Sign in to comment
scite_
Similar content
3,422
Escitalopram oxalate: co-existence of oxalate dianions and oxalic acid molecules in the same crystal.
Authors:
William T A Harrison
,
H. Yathirajan
,
S. Bindya
…
Anxiety symptom remission is associated with genetic variation of PTPRZ1 among patients with major depressive disorder treated with escitalopram.
Authors:
Yun-Ai Su
,
Chad A Bousman
,
Qi Liu
…
Escitalopram in the long-term treatment of major depressive disorder.
Authors:
Alan G Wade
,
Nicolas Despiégel
,
Elin Heldbo Reines
See all similar
Cited by
364
Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression
Authors:
Guy M. Goodwin
,
Scott Aaronson
,
Oscar Álvarez
…
Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder : A Randomized Clinical Trial
Authors:
Michael P Bogenschutz
,
Stephen Ross
,
Snehal R. Bhatt
…
Increased global integration in the brain after psilocybin therapy for depression
Authors:
Richard E. Daws
,
Christopher Timmermann
,
Bruna Giribaldi
…
See all cited by